The WINTHER study

Use of electronic data to raise the standard of cancer care

Drugging the cancer genome: opportunities and challenges

A new direction for development of targeted cancer therapies

Online collaborations to aid treatment development

Addressing Asia’s high cancer incidence

Vandetanib increases progression free survival in medullary thyroid carcinoma

WINTHER: The WIN therapeutics clinical trial

Use of genetic variance to identify potential therapeutic targets

Introduction of PET tracers to the WINTHER trial

Application of next generation sequencing

Next generation sequencing and WIN therapeutics

Identifying targets with systems medicine

Importance of early detection and the ‘Beyond the Shock’ programme

Shortening the timeline for clinical drug developments

Building international collaborations and the WINTHER trial